HCV Therapy With Daclatasvir, PEG-IFN, and RBV After Boceprevir-Based Therapy Failure Post-Liver Transplantation in Hyper-IgM Syndrome

被引：3
|
作者：
Reddy, K. Rajender [1 ]
Wirjosemito, Amina [1 ]
Pavri, Tanya M. [1 ]
Sinese, Lorie [1 ]
机构：
[1] Univ Penn, Perelman Sch Med, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA
来源：
TRANSPLANTATION | 2014年 / 97卷 / 08期
关键词：
HEPATITIS-C; INFECTION;
D O I：
10.1097/TP.0000000000000076
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E47 / E48
页数：2
相关论文
共 15 条
  • [1] Recurrence of hepatitis C after liver transplantation: Results of PEG-IFN and ribavirin combination therapy
    Dumortier, J
    Scoazec, JY
    Boillot, O
    LIVER TRANSPLANTATION, 2003, 9 (06) : C44 - C44
  • [2] Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)
    Fontaine, Helene
    Maynard, Marianne
    Bouix, Cecile
    Carrieri, Maria Patrizia
    Botta-Fridlund, Danielle
    D'Alteroche, Louis
    Conti, Filomena
    Pageaux, Georges-Philippe
    Leroy, Vincent
    Metivier, Sophie
    Anty, Rodolphe
    Durand, Francois
    Canva, Valerie
    Vilotitch, Antoine
    Lebray, Pascal
    Alric, Laurent
    Duvoux, Christophe
    Petrov-Sanchez, Ventzislava
    Beaulieux, Frederik
    Wellems, Celia
    Paul, Christelle
    Roque-Afonso, Anne-Marie
    Roche, Bruno
    Pradat, Pierre
    Samuel, Didier
    Duclos-Vallee, Jean-Charles
    Bailly, Francois
    Dharancy, Sebastien
    Grange, Jean-Didier
    Guidoum, Amir
    Hezode, Christophe
    Serfaty, Awrence
    Si-Ahmeda, Si-Nafa
    Sizorn, Michelle
    Taburet, Anne-Marie
    Teicher, Elina
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (01) : 56 - 65
  • [3] Application of a high-resolution melting technique for the rapid detection of partial replacement of HCV-1b by HCV-1a after PEG-IFNα/RBV therapy
    Holysz, M.
    Bialas, K.
    Migdalski, P.
    Kmieciak, D.
    Trzeciak, W. H.
    JOURNAL OF APPLIED GENETICS, 2015, 56 (02) : 271 - 275
  • [4] Application of a high-resolution melting technique for the rapid detection of partial replacement of HCV-1b by HCV-1a after PEG-IFNα/RBV therapy
    M. Holysz
    K. Bialas
    P. Migdalski
    D. Kmieciak
    W. H. Trzeciak
    Journal of Applied Genetics, 2015, 56 : 271 - 275
  • [5] ACCURATE PERSONALIZATION OF PEG-IFN plus RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1ST MONTH OF THERAPY
    Colombatto, P.
    Romagnoli, V.
    Civitano, L.
    Ciccorossi, P.
    Maina, A. M.
    Oliveri, F.
    Coco, B.
    Cherubini, B.
    Bonino, F.
    Brunetto, M. R.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S105 - S105
  • [6] Safety and Efficacy of Telaprevir-Based Triple Therapy to Treat HCV Recurrence Post-Liver Transplantation
    Singh, Tavankit
    Singh, Gurshawn
    Fung, John J.
    Zein, Nizar N.
    Eghtesad, Bijan
    Alkhouri, Naim
    GASTROENTEROLOGY, 2014, 146 (05) : S980 - S980
  • [7] PREVALENCE AND EFFECT OF GRAFT VS RECIPIENT IL28B SNP ON EARLY HCV-RNA KINETICS IN PATIENTS ON PEG-IFN/RBV AFTER LIVER TRANSPLANTATION
    Barcena, R.
    del Campo, S.
    Moreno, Ana
    Sanmillan, J. L.
    Muriel, A.
    Rodriguez-Gandia, M. A.
    Achecar, L.
    Graus, J.
    Fortun, J.
    Meije, Y.
    Nuno, J.
    Mateos, M. L.
    Moreno, S.
    Varona, C.
    Moreno, Alberto
    JOURNAL OF HEPATOLOGY, 2011, 54 : S519 - S520
  • [8] Liver related events and survival in patients with compensated HCV cirrhosis: The role of sustained virological response to PEG-IFN based therapy and portal hypertension
    Calvaruso, V.
    Di Marco, V.
    Ferraro, D.
    Pizzillo, P.
    Alaimo, G.
    Craxi, A.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S99 - S99
  • [9] LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION
    Calvaruso, V.
    Di Marco, V.
    Ferraro, D.
    Pizzillo, P.
    Alaimo, G.
    Craxi, A.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S65 - S66
  • [10] NS5A variability and dynamics of resistance-associated mutations in HCV genotype 4 patients, naive to treatment receiving triple therapy with DACLATASVIR plus PEG-IFN/RBV, assessed by ultra deep sequencing
    Bartolini, Barbara
    Lionetti, Raffaella
    Giombini, Emanuela
    Taibi, Chiara
    Montalbano, Marzia
    D'Offizi, Gianpiero
    McPhee, Fiona
    Hughes, Eric A.
    Ippolito, Giuseppe
    Garbuglia, Anna Rosa
    Capobianchi, Maria R.
    HEPATOLOGY, 2014, 60 : 917A - 917A
12